Docusate Sodium Oral Liquid
- Product NDC
- 81033-022
- 11-digit product format
- 810330022
- Labeler code
- 81033
- Product ID
- 81033-022_331277b8-8305-d082-e063-6394a90a4dd3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate Sodium Oral Liquid
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Kesin Pharma Corporation
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-04-01
- Substance
- DOCUSATE SODIUM
- Active strength
- 100 mg/10mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Docusate Sodium Oral Liquid
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOCUSATE SODIUM | 100 mg/10mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F05Q2T2JA0 |
| Rxcui | 1248119 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 81033-022-10 | Docusate Sodium Oral Liquid | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | | 1 |
| 81033-022-50 | Docusate Sodium Oral Liquid | 100 in 1 CASE | LIQUID | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 81033-022 | DOCUSATE SODIUM ORAL LIQUID LIQUID [KESIN PHARMA CORPORATION] | 1 | Current NDC, 2 package rows | 20250427_331277b8-8304-d082-e063-6394a90a4dd3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 81033-022-10 | 81033002210 | 10 mL in 1 CUP, UNIT-DOSE | 10 ml | | | | Historical |
| 81033-022-50 | 81033002250 | 100 CUP, UNIT-DOSE in 1 CASE (81033-022-50) / 10 mL in 1 CUP, UNIT-DOSE (81033-022-10) | | 2025-04-01 | No | No | Current |